期刊文献+

牛种布鲁氏菌TLR9_CpG_DNA免疫信号通路活性检测

Evaluation of TLR9_Cp G_DNA Signaling Pathway Activity From Brucella Abortus
下载PDF
导出
摘要 目的检测牛种布鲁氏菌TLR9_Cp G_DNA免疫信号通路活性。方法 NCBI网站上下载Brucella abortus A13334全部基因组序列,利用生物信息学的方法筛选Cp G基序,合成天然骨架的脱氧寡核苷酸(ODNs),转染小鼠单核巨噬细胞株RAW264.7收集上清,Elisa检测炎性因子干扰素IFN-α的分泌水平。结果共筛选出1 935条牛种布鲁氏菌Cp G,选其中二级茎环结构较好的5条序列合成ODNs,Elisa结果显示,序列M1分泌的IFN-α浓度与对照序列相比表达量增高差异有统计学意义。结论宿主TLR9识别牛种布鲁氏菌Cp G基序,从而活化免疫信号通路。 Objective The aim of this study was to screen natural DNA sequences named CpG with TLR9 agonistic activity from Brucella abortus. Method Complete genome sequence of Brucella abortus A13334 was available in genebank. Bioinformatics technology was used to identify Brucella abortus CpG. Phosphodiester ODNs representing the selected ODNs were then synthesized. Murine macrophage RAW264.7 were cultured and transfected with ODNs. The content of IFN - a in the supernatant was then measured by ELISA. Result Totally screened 1 935 CpG in abortus brucella, 5 CpG sequences was synthesized to ODNs. Elisa results showed compared with the control sequence, the difference of Concentration of IFN - α in RAW264.7 cells originate from sequence M1 was statistically increased. Conclusion This work demonstrated that CpG sequences present in Brucella abortus DNA were able to produce macrophages stimulation through TLR9.
出处 《内蒙古医学杂志》 2016年第4期399-401,共3页 Inner Mongolia Medical Journal
基金 国家自然科学基金(81360242) 内蒙古自治区杰出青年培育基金(2014JQ04) 内蒙古自治区自然科学基金(2014MS0808 2015MS0810)
关键词 布鲁氏菌 CPG TOLL样受体9 干扰素Α brucella CpG TLR9 IFN - α
  • 相关文献

参考文献9

  • 1Chuang TH,Lee J,Kline L,et al.Toll like receptor 9 mediates Cp G-DNA signaling[J].JLeukoc Bio,2002,71(3):538-544.
  • 2Celli J.Surviving inside a macrophage:the many ways of Brucella[J].Res Microbiol,2006,157(2):93-98.
  • 3Hashimoto D,Miller J,Merad M.Dendritic cell and macrophage heterogeneity in vivo[J].Immunity,2011,35(3):323-335.
  • 4Holtick U,Scheulen ME,von Bergwelt-Baildon MS,et al.Tolllikereceptor 9 agonists as cancer therapeutics[J].Expert Opin Investig Drugs,2011,20(3):361-372.
  • 5Urry Z,Xystrakis E,Richards DF,et al.Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha,25-dihydroxyvitamin D3abrogates regulatory function[J].J Clin Invest,2009,119(2):387-398.
  • 6Jaroslav N,Irena L,Bohdan S.Evolution of REP diversity:a comparative study[J].BMC Genomics,2013,14:385.
  • 7桑丽敏,唐立.TLR9的特性及其介导的TLR9/CpG-DNA免疫信号通路[J].中国微生态学杂志,2010,22(12):1143-1146. 被引量:5
  • 8Hayden MS,Ghosh S.NF-κB,the first quarter-century:remarkable progress and outstanding questions[J].Genes Dev,2012,26(3):203-234.
  • 9Macedo GC,Magnani DM,Carvalho NB,et al.Central role of My D88-dependent dendritic cell maturation and proinflam matry cytokine production to control brucella abortus in fection[J].J Immunol,2008,180:1 080-1 087.

二级参考文献44

  • 1CHEN R, ALVERO A B, SILASI D A, et al. Cancers take their Toll the function and regulation of Toll-like receptors in cancer ceils[ J]. Oncogene,2008,27 ( 2 ) :225-233.
  • 2TAKEDA K, KAISHO T, AKIRA S, et al. Toll-like receptors[ J]. Annu Rev Immunol,2003,21:335-376.
  • 3MEDZHITOV R. Toll-like receptors and innate immunity[ J]. Nat Rev Immunol,2001,1 (2) : 135-145.
  • 4TAKEDA K, AKIRA S. Roles of Toll-like receptors in innate immune responses[ J]. Genes CellS,2001,6(9) :733-742.
  • 5CARIO E. Bacterial interactions with cells of the intestinal mucosa Toll-like receptors and NOD2 [ J ]. Gut, 2005,54 ( 8 ) : 1182 -1193.
  • 6AKASHI S,SHIMAZU R,OGATA H,et al. Cutting dege:cell surface expresssion and lipopolysaccharide signaling via the Toll-like receptor 4-MD 2 complex on mouse peritoneal macrophages [ J ]. J Immunol, 2000,164 ( 7 ) : 3471-3475.
  • 7AKIM S ,TAKEDA K, KAISHO T. Toll-like receptors : critical protein linking innate and acquired immunity[ J]. Nat Immunol,2001,2 (8) : 675-680.
  • 8CARIO E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and Nod2 [J]. Gut,2005,54 ( 8 ) : 1182-1193.
  • 9ALBIGER B, DAHLBERG S, HENRIQUES-NORMARK B, et al. Role of the innate immune system in host defence against bacterial infections:focus on the Toll-like receptors[J]. Int Med,2007,261 (6) :511- 528.
  • 10MOLLNES. Hypothesis:combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response[ J]. Adv Exp Med Biol,2008,632(4) :253-263.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部